Atlas Trials

A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in India

Clinical trial NCT05502562 · COMPLETED

Trial details

NCT number
NCT05502562
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Study type
OBSERVATIONAL
Diabetes Mellitus, Type 2
Start date
2023-02-24
Primary completion
2024-06-03
Enrollment
388

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.